John Wareham, Peter Leddy, Shaf Yousaf, David Julien, Gilles Cottier, Frank Wicks, Douglas Liu, GE, Roche, Thermo, Beckman, Waters, European Commission, Assay Designs, Stressgen Bioreagents | GenomeWeb

People

John Wareham, who retired from his position as chairman and CEO of Beckman Coulter in February, entered into a retirement and consulting agreement with the company on June 30, according to an 8-K filing with the US Securities and Exchange Commission. Wareham will serve as a consultant for three years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.